homefeedbacksupportlog on 7-Oct-2008 
  About F1000

 What is F1000 Biology?
 Key features
 How it's organized
 FAQs
 Faculties and sections
 Scope of sections
 List of Faculty Members
 The evaluation system
 Citing F1000
 Take a tour of the site
 Accessing fulltexts
 PubMed linkout
 How to subscribe
 Academic subscriptions
 Corporate subscriptions
 Try F1000 for free
 Who we are
 Media information
 Librarian resources
 Press releases
 In the press
 Developing countries
 F1000 Medicine
 Terms and conditions
 Privacy policy
 Contact us


David J Webb
Centre for Cardiovascular Science, University of Edinburgh, Edinburgh, United Kingdom

Faculty Member: Pharmacology & Drug Discovery > Cardiovascular Pharmacology [ since 2 June 2006 ]
[ Evaluations ]
to email [Help]
Evaluations

Converging evidence in support of the serotonin hypothesis of dexfenfluramine-induced pulmonary hypertension with novel transgenic mice.
Dempsie Y, Morecroft I, …, Bader M, MacLean MR
Circulation 2008 Jun 3 117(22):2928-37 [abstract on PubMed] [related articles] [full text] [order article]
Selected by | David J Webb
Evaluated 20 Jun 2008

Collecting duct-derived endothelin regulates arterial pressure and Na excretion via nitric oxide.
Schneider MP, Ge Y, …, Pollock JS, Kohan DE
Hypertension 2008 Jun 51(6):1605-10 [abstract on PubMed] [related articles] [full text] [order article]
Selected by | David J Webb
Evaluated 20 Jun 2008

Absence of Cyclooxygenase-2 Exacerbates Hypoxia-Induced Pulmonary Hypertension and Enhances Contractility of Vascular Smooth Muscle Cells.
Fredenburgh LE, Liang OD, …, Kourembanas S, Perrella MA
Circulation 2008 Apr 7 [abstract on PubMed] [related articles] [full text]
Selected by | David J Webb
Evaluated 17 Apr 2008

Endothelin receptor antagonism prevents hypoxia-induced mortality and morbidity in a mouse model of sickle-cell disease.
Sabaa N, de Franceschi L, …, Dussaule JC, Tharaux PL
J Clin Invest 2008 Apr 1 [abstract on PubMed] [related articles] [FREE full text]
Selected by | David J Webb
Evaluated 11 Apr 2008

Angiotensin II causes hypertension and cardiac hypertrophy through its receptors in the kidney.
Crowley SD, Gurley SB, …, Le TH, Coffman TM
Proc Natl Acad Sci U S A 2006 Nov 21 103(47):17985-90 [abstract on PubMed] [related articles] [FREE full text]
Selected by | Matthew Breyer / Soeren Sheikh / Raymond Harris / Anna Dominiczak / Tom Lohmeier / David J Webb / Robert Carey
Evaluated 4 Apr 2007


Late-onset endothelin-A receptor blockade reduces podocyte injury in homozygous Ren-2 rats despite severe hypertension.
Opocenský M, Kramer HJ, …, Tesar V, Vanecková I
Hypertension 2006 Nov 48(5):965-71 [abstract on PubMed] [related articles] [FREE full text]
Selected by | David J Webb
Evaluated 16 Oct 2006

^Top  Back to Faculty Members


© 1999-2008 Biology Reports Ltd unless otherwise stated < info@f1000.com >   Terms and conditions   Legal info